Bank Of America Corp Kodiak Sciences Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Bank Of America Corp holds 295,156 shares of KOD stock, worth $785,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares

295,156

Previous 287,014 2.84%

Holding current value

$785,114

Previous $1.51 Million 54.08%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.29 - $4.48 $18,645 - $36,476	8,142 Added 2.84%	295,156 $693,000
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $654,903 - $1.62 Million	217,576 Added 313.34%	287,014 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $28,155 - $65,159	20,111 Added 40.77%	69,438 $211,000
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $41,993 - $92,581	9,766 Added 24.69%	49,327 $340,000
Q1 2023 May 12, 2023	SELL	$4.81 - $8.88 $30,553 - $56,405	-6,352 Reduced 13.83%	39,561 $245,000
Q4 2022 Feb 10, 2023	SELL	$6.52 - $8.05 $146,537 - $180,923	-22,475 Reduced 32.86%	45,913 $328,000
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $93,799 - $154,887	-12,391 Reduced 15.34%	68,388 $530,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.48 $26,293 - $49,457	5,217 Added 6.9%	80,779 $617,000
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $101,387 - $1.28 Million	14,300 Added 23.34%	75,562 $583,000
Q4 2021 Feb 08, 2022	BUY	$80.85 - $128.49 $2.58 Million - $4.1 Million	31,889 Added 108.57%	61,262 $5.19 Million
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $2.54 Million - $3.31 Million	-30,975 Reduced 51.33%	29,373 $2.82 Million
Q2 2021 Sep 13, 2021	BUY	$77.2 - $126.54 $4.66 Million - $7.64 Million	60,348 New	60,348 $5.61 Million

Others Institutions Holding KOD

# of Institutions

104

Shares Held

39.8M

Call Options Held

7.6K

Put Options Held

3.5K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Kodiak Sciences Inc. Transaction History